2016
DOI: 10.1002/iub.1531
|View full text |Cite
|
Sign up to set email alerts
|

Basic fibroblast growth factor promotes melanocyte migration via activating PI3K/Akt‐Rac1‐FAK‐JNK and ERK signaling pathways

Abstract: Vitiligo is a depigmentation disorder characterized by loss of functional melanocytes of the skin epidermis. The pathogenesis of vitiligo remains elusive. The purpose of this study is to investigate the effects of basic fibroblast growth factor (bFGF) on melanocyte migration, including its biochemical mechanism using transwell assay in vitro. We found that melanocyte treated with bFGF showed a significant increase in migration and cytoskeletal rearrangement. These changes were associated with increased activat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

2
29
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 34 publications
(34 citation statements)
references
References 63 publications
2
29
0
Order By: Relevance
“…However, tumors in different locations may have alternate mechanisms of melanocyte colonization . We immunostained for several molecules that have been reported to affect melanocyte migration . We show that the receptor CD117 (c‐Kit) is expressed in a subset of the recurrent tumor's melanocytes and that its ligand, SCF (KITL), is diffusely expressed in the meningioma cells.…”
Section: Discussionmentioning
confidence: 90%
See 3 more Smart Citations
“…However, tumors in different locations may have alternate mechanisms of melanocyte colonization . We immunostained for several molecules that have been reported to affect melanocyte migration . We show that the receptor CD117 (c‐Kit) is expressed in a subset of the recurrent tumor's melanocytes and that its ligand, SCF (KITL), is diffusely expressed in the meningioma cells.…”
Section: Discussionmentioning
confidence: 90%
“…24 We immunostained for several molecules that have been reported to affect melanocyte migration. [17][18][19][20][21][22][23] We show that the receptor CD117 (c-Kit) is expressed in a subset of the recurrent tumor's melanocytes and that its ligand, SCF (KITL), is diffusely expressed in the meningioma cells. Also, bFGF is diffusely expressed in the recurrent tumor ( Fig.…”
Section: Discussionmentioning
confidence: 94%
See 2 more Smart Citations
“…VX-11e, an ERK2 inhibitor, inhibited the ERK2 activation in cervical carcinoma cells with either CKAP2 overexpression or not. FAK acts as a linker of transmembrane receptors with the major growth regulatory pathways, including extracellular signal-related kinase (ERK) and c-Jun-N-terminal kinase (JNK)/mitogen-activated protein kinase (MAPK) pathways 33 . Downregulating MMP-2/9 via inhibiting the activation of ERK/MAPK signaling pathways inhibited migration and invasion of colorectal cancer 34 .…”
Section: Discussionmentioning
confidence: 99%